Biotech · Private company
MoonLake Immunotherapeutics AG
Track this companyFree. Adds MoonLake Immunotherapeutics AG to your Dealase workspace and tells you when its record changes.
Clinical trials94 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- RisankizumabPhase 3 · Arthritis, PsoriaticClinicalTrials.gov · fetched Nov 12, 2026
- SonelokimabPhase 3 · Arthritis, PsoriaticClinicalTrials.gov · fetched Nov 12, 2026
- SonelokimabPhase 3 · Hidradenitis SuppurativaClinicalTrials.gov · fetched Nov 12, 2026
- AdalimumabPhase 2 · Arthritis, PsoriaticClinicalTrials.gov · fetched Nov 12, 2026
- AdalimumabPhase 2 · Hidradenitis SuppurativaClinicalTrials.gov · fetched Nov 12, 2026
- Sonelokimab (M1095)Phase 2 · Hidradenitis SuppurativaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic ArthritisPHASE3 · ENROLLING_BY_INVITATION · started Nov 13, 2025ClinicalTrials.gov NCT07223138 · fetched Nov 12, 2026
- A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis SuppurativaPHASE3 · ENROLLING_BY_INVITATION · started Jun 27, 2025ClinicalTrials.gov NCT07007637 · fetched Nov 12, 2026
- An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)PHASE3 · COMPLETED · started Dec 30, 2024ClinicalTrials.gov NCT06768671 · fetched Nov 12, 2026
- Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 15, 2024ClinicalTrials.gov NCT06641076 · fetched Nov 12, 2026
- Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePHASE3 · ACTIVE_NOT_RECRUITING · started Oct 15, 2024ClinicalTrials.gov NCT06641089 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaPHASE3 · COMPLETED · started May 15, 2024ClinicalTrials.gov NCT06411899 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaPHASE3 · COMPLETED · started May 14, 2024ClinicalTrials.gov NCT06411379 · fetched Nov 12, 2026
- Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisPHASE2 · COMPLETED · started Dec 13, 2022ClinicalTrials.gov NCT05640245 · fetched Nov 12, 2026
- Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis SuppurativaPHASE2 · COMPLETED · started Apr 25, 2022ClinicalTrials.gov NCT05322473 · fetched Nov 12, 2026